The global Orthopedic Biomaterials Market size to reach around US$ 26.5 Bn by 2027 and is anticipated to grow at a CAGR of around 9.83% from 2020 to 2027.
Precedence Research, Recently Published Report on “ Orthopedic Biomaterials Market Size, Share, Growth, Trends, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
Orthopedic biomaterials are natural or synthetic material used to replace an organ in the human body. They are generally required in surgical implants, orthopedics, prosthetics and others. Various biomaterial based medical devices comprise stents, heart walls, hip joints, artificial knee, etc. Biomaterials aid in the innovations of regenerative medicines.
These products are customized to perform numerous biological functions by repairing certain tissues in the human body. For instance, the orthopedic biomaterials are used for joint reconstruction, spine implants, bio resorbable tissue fixation and orthobiologics. In several regions such as North America, Asia, and Japan the government regulated the use of biomaterials which are of high quality. The biomaterials are implanted into human body hence would require safety and efficiency approval for marketing. Further, as these biomaterials are implanted in the human body, they should be biocompatible and must pass the ISO biocompatibility testing standards.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1107
Growth Factors
Growing prevalence of musculoskeletal diseases and disorders are the key driving factors for the growth of orthopedic biomaterials market. The reason for the occurrences of musculoskeletal disorder is orthopedic trauma or injury which affect the muscles, ligaments, tendons, bone and nervous. The orthopedic trauma affects the musculoskeletal systems. Increasing usage of nanoparticles in to orthopedic bioimplant will further propel the growth of the market. Currently, R&D activities into in the healthcare sector continuously focus to develop the treatment, therapies and medications for degenerative diseases. One of the crucial influences for the market growth is changing consumer preferences from traditional materials to nanophase materials. Considerable benefits of biomaterials led substantial inventions in the regenerative medicines sector in the past couple of years. Increasing awareness among young generations towards health care and increasing geriatric population is expected to boost the growth of the orthopedic biomaterials market. Additionally, increasing demand for medical implant, substantial growth in the cardiovascular diseases escalates the growth of the market. However, procedure of manufacturing biomaterials is very time consuming and must go through biocompatibility testing and clinical trials which hampers the market growth. Nonetheless, growth in the adoption of implantable devices, increasing patient population and availability of flexible government regulations in the emerging region is projected to offer significant growth avenues for orthopedic biomaterials market over the forecast period.
View Full Report with Complete ToC@ https://www.precedenceresearch.com/orthopedic-biomaterials-market
Regional Snapshots
Regionally, the orthopedic biomaterials market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America dominated global orthopedic biomaterials market in 2019 owing to increasing demand for technologically advanced orthopedic implants. North America is projected to further mirror this trend throughout the prediction period. As per National Health Statistics Report, 209 million Americans participated in sports and fitness activity in 2013, which is increased up to 213 million 2015. This has resulted in increased number of orthopedic surgeries including joint reconstruction, joint arthroplasty and viscoupllementation.
Europe closely followed North America owing to cumulative orthopedic surgery cases and increasing focus on health care. Lack of awareness and availability of treatment facilities in the Middle East and Africa witness the slow growth in the orthopedic biomaterials market.
Asia Pacific is expected to record the highest CAGR over the forecast period. Growing healthcare industry in Japan, budding demand for cosmetic and plastic surgeries in India and less stringent tax policy in China and escalating elderly population drives the orthopedic biomaterials market significantly in this region.
Report Highlights
- Companies involved in the marketplace are focusing on developing innovative orthopedic biomaterials at competitive prices.
- The arrival of 3D printing is projected to substantially enhance the demand for orthopedic biomaterials due to benefits coupled with fabricating scaffolds.
- Increasing prevalence of bone degenerative diseases and bone disorders in low- and middle-income countries drives the regional market growth.
- Significant average selling price of the orthopedic implants, favorable coverage of orthopedic procedure and growing demand for technologically advanced orthopedic implants from surgeons with enhanced lifetime and quality flourishes the growth in developed region.
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
Major players in orthopedic biomaterials are Acumed, LLC. Medtronic plc, Globus Medical, Inc., Stryker Corporation, Koninklijke DSM N.V., Exactech, Inc., Johnson & Johnson, Zimmer Biomet, Wright Medical Group, Inc., and NuVasive, Inc. among others. In July 2020, Medtronic plc, a global leader in medical technology acquired Medicrea. This acquisition would strengthen the Medtronic’s position as global innovator in enabling technologies and solutions for the spine surgery. Stryker acquired Mako Surgical Corp. in order to construct total knee and total hip replacement robotic products. Further, in year 2016, Zimmer Biomet acquired LDR Holdings to make their spine segment stronger and enhance growth of its sports medicine segment.
Market Segmentation
By Material Outlook
- Polymers
- Ceramics & Bioactive Glasses
- Calcium Phosphate Cement
- Composites
- Metal
By Application Outlook
- Orthobiologics
- Orthopedic Implants
- Viscosupplementation
- Joint Replacement
- Bio-resorbable Tissue Fixation
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Biomaterials Market, By Material
7.1. Orthopedic Biomaterials Market, by Material Type, 2020-2027
7.1.1. Polymers
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Ceramics & Bioactive Glasses
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Calcium Phosphate Cement
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Composites
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Metal
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Orthopedic Biomaterials Market, By Application
8.1. Orthopedic Biomaterials Market, by Application, 2020-2027
8.1.1. Orthobiologics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Orthopedic Implants
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Viscosupplementation
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Joint Replacement
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Bio-resorbable Tissue Fixation
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Orthopedic Biomaterials Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
Chapter 10. Company Profiles
10.1. Acumed, LLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Globus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Koninklijke DSM N.V.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Exactech, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zimmer Biomet
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Wright Medical Group, Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1107
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
Follow us on LinkedIn| Twitter| Facebook
0 Comments